Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Lucas GC | LGCL | Apr 17, 2025 | 0.37 | -3.58 |
Lucid Diagnostics | LUCD | Apr 17, 2025 | 1.21 | +11.01 |
Lucid Group | LCID | Apr 17, 2025 | 2.38 | +3.03 |
Lucky Strike Entertainment A | LUCK | Apr 17, 2025 | 8.54 | +2.28 |
Luda Technology Group Limited | LUD | Apr 17, 2025 | 4.16 | 0.00 |
Lufax ADR | LU | Apr 17, 2025 | 2.36 | -2.88 |
Lululemon Athletica | LULU | Apr 17, 2025 | 251.08 | +0.69 |
Lulus Fashion Lounge | LVLU | Apr 17, 2025 | 0.45 | -0.44 |
Lumen Technologies | LUMN | Apr 17, 2025 | 3.29 | +0.30 |
Lument Finance Trust | LFT | Apr 17, 2025 | 2.63 | +1.94 |
Lument Finance Trust A Pref | LFT-A | Apr 17, 2025 | 21.09 | 0.00 |
Lumentum | LITE | Apr 17, 2025 | 52.00 | -0.40 |
Luminar Technologies A | LAZR | Apr 17, 2025 | 3.80 | +14.11 |
Luokung Technology | LKCO | Apr 17, 2025 | 0.81 | 0.00 |
Luxfer | LXFR | Apr 17, 2025 | 9.85 | -3.05 |
Lxp Industrial Trust | LXP | Apr 17, 2025 | 7.76 | +0.52 |
LXP Industrial Trust C Pref | LXP-C | Apr 17, 2025 | 44.52 | -1.21 |
Lyell Immunopharma | LYEL | Apr 17, 2025 | 0.43 | -1.23 |
Lyft A | LYFT | Apr 17, 2025 | 11.16 | +2.95 |
LyondellBasell Industries Nv A | LYB | Apr 17, 2025 | 56.77 | +1.48 |
Lyra Therapeutics | LYRA | Apr 17, 2025 | 0.09 | -5.98 |
Lytus Technologies | LYT | Apr 17, 2025 | 0.10 | 0.00 |
LZ Technology B | LZMH | Apr 17, 2025 | 9.12 | 0.00 |
M&T Bank | MTB | Apr 17, 2025 | 160.23 | +0.84 |
M&T Bank ADR Prej J | MTB-J | Apr 17, 2025 | 26.09 | +0.27 |
M&T Bank H Pref | MTB-H | Apr 17, 2025 | 23.95 | +0.10 |
M-tron Industries | MPTI | Apr 17, 2025 | 51.47 | +5.77 |
M/I Homes | MHO | Apr 17, 2025 | 106.19 | +1.97 |
M3-Brigade Acquisition V | MBAV | Apr 17, 2025 | 10.23 | 0.00 |
M3-Brigade Acquisition V | MBAVU | Apr 17, 2025 | 10.35 | 0.00 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.